Headline »

Infuse Lawsuit Update:  Medtronic’s Effort To Escape Liability Rejected

Infuse Lawsuit Update: Medtronic’s Effort To Escape Liability Rejected

August 22, 2013 – 11:48 pm | No Comment

A Federal court in Arizona on August 21, 2013, rejected Medtronic’s motion to dismiss a personal injury lawsuit brought by a patient who alleges Medtronic fraudulently promoted Infuse, a bio-engineered bone graft substitute that spurs …

Read the full story »

clinical trials, FDA, government investigation, Headline, Litigation, medical devices, patient health »

Infuse Lawsuit Update: Medtronic’s Effort To Escape Liability Rejected

August 22, 2013 – 11:48 pm | No Comment

Infuse Lawsuit Update:  Medtronic’s Effort To Escape Liability Rejected

A Federal court in Arizona on August 21, 2013, rejected Medtronic’s motion to dismiss a personal injury lawsuit brought by a patient who alleges Medtronic fraudulently promoted Infuse, a bio-engineered bone graft substitute that spurs bone growth. Read the full story »

Independent Researchers Find Infuse Bone Graft Offers No Advantages Over Traditional Spine Surgery

June 19, 2013 – 9:33 pm | No Comment
Independent Researchers Find Infuse Bone Graft Offers No Advantages Over Traditional Spine Surgery

On Monday, June 17, two independent groups of researchers found that Infuse, a bioengineered bone growth protein manufactured by Medtronic, offers no advantages over traditional spine surgery.

Medtronic Under Pressure After Release of Senate Study

January 7, 2013 – 10:25 am | Comments Off
Medtronic Under Pressure After Release of Senate Study

A report last month by a U.S. Senate Finance Committee report raises new concerns about the safety and effectiveness of BMP-2, also known as bone morphogenetic protein-2, widely used in spinal fusion surgery.

The Spine Journal Praised in Senate Committee Findings

November 7, 2012 – 4:52 pm | Comments Off
The Spine Journal Praised in Senate Committee Findings

In an investigation by the U.S. Senate Committee on Finance on physician/industry relationships, scientific publishing and the marketing of Medtronic products used in spinal surgeries, The Spine Journal was singled out for its dedication to …

Medtronic Paid $210 million for Pro-Infuse Medical Papers, Senate Investigators Find

October 25, 2012 – 2:28 pm | Comments Off
Medtronic Paid $210 million for Pro-Infuse Medical Papers, Senate Investigators Find

Medtronic paid $210 million to 13 doctors to author a series of now-repudiated positive reviews and not reveal any side effects linked to using its bone graft product, Infuse

Courts Reject Efforts by Medtronic To Close Doors To Courthouse

August 23, 2012 – 11:52 am | Comments Off
Courts Reject Efforts by Medtronic To Close Doors To Courthouse

Two courts have recently ruled that lawsuits may proceed and are not preempted where the injured patient alleges that the device manufacturer engaged in off-label promotion of medical devices, in violation of the Food Drug, …

Medtronic Settles Infuse Shareholder Lawsuit at $85 Million

April 2, 2012 – 12:27 pm | Comments Off
Medtronic Settles Infuse Shareholder Lawsuit at $85 Million

Reuters reports, Medtronic Inc., manufacturer of controversial and allegedly dangerous Infuse bone graft, has settled a shareholder lawsuit by paying $85 million to shareholders accusing it of making misleading statements concerning its Infuse bone graft …

Spinal Surgeon Received Over $25 Million in Royalties from Medtronic

January 4, 2012 – 5:06 pm | Comments Off
Spinal Surgeon Received Over $25 Million in Royalties from Medtronic

The Milwaukee-Wisconsin Journal Sentinel reports that Dr. Thomas Zdeblick, a spinal surgeon and chair of the University of Wisconsin’s orthopedic department, has received over $25 million in royalty payments from Medtronic since 2003.

Medtronic Infuse Bone Graft Subjected to U.S. Senate Investigation

December 19, 2011 – 11:46 am | Comments Off
Medtronic Infuse Bone Graft Subjected to U.S. Senate Investigation

U.S. Senators Charles Grassley, Richard Blumenthal and Herb Kohl have introduced the Medical Device Patient Safety Act, designed to give the Food and Drug Administration (FDA) tools to better monitor post-market performance of new medical …

Medtronic Pays $23.5 Million to End Government False Claims Investigation

December 13, 2011 – 6:11 pm | 2 Comments
Medtronic Pays $23.5 Million to End Government False Claims Investigation

Mercury News reports that Medtronic, Inc. has agreed to pay $23.5 million to the U.S. Justice Department to settle claims that the company paid kickbacks to doctors to implant its pacemakers and defibrillators.

California Attorney General Issues Subpoena for Infuse Bone Graft Documents

December 12, 2011 – 12:11 pm | 2 Comments
California Attorney General Issues Subpoena for Infuse Bone Graft Documents

Medtronic, Inc. disclosed last week that California Attorney General Kamala Harris issued a subpoena on October 14, 2011, for documents related to its Infuse bone graft product.